Method for preparing abiraterone acetate without heavy-metal residue

A technology of abiraterone acetate and acid-binding agent, which is applied in the production of steroids, bulk chemicals, organic chemistry, etc., can solve the problems of unsuitability for large-scale production, harsh operation methods, unfavorable material preparation and operation, etc., and achieve good Prospect of industrial application and effect of cost reduction

Active Publication Date: 2013-04-24
SUZHOU LEINA PHARMA RES DEV
View PDF4 Cites 19 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0013] However, the reaction time is long, the energy consumption is high, and the requirements for the reaction vessel are relatively high. At the same time, the raw material diethyl (3-pyridyl) borane is very expensive, and column chromatographic separation is required in the reaction process, which is not

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for preparing abiraterone acetate without heavy-metal residue
  • Method for preparing abiraterone acetate without heavy-metal residue
  • Method for preparing abiraterone acetate without heavy-metal residue

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0045] Example 1 Synthesis of Abiraterone Acetate

[0046] (1) Protection of hydroxyl

[0047] Dissolve 10.0 g of dehydroepiandrosterone in 80 ml of THF, add 3.5 g of 3,4-dihydro-2H-pyran (DHP) under stirring at room temperature, and add 0.5 ml of trifluoroacetic acid as a catalyst. The reaction solution is stirred at room temperature for 10- 12h.

[0048] The reaction solution was desolventized under reduced pressure, the residue was dissolved in 100ml water and 100ml ethyl acetate, and the layers were separated. The aqueous phase was extracted twice with 50ml of ethyl acetate each time. The ethyl acetate phases were combined and washed once with 150ml of water. Washed with 150ml saturated brine once, dried with anhydrous sodium sulfate and desolubilized to obtain 11.5g of product (yield 89%), without purification, it can be used directly in the next reaction.

[0049] (2) Aldol reaction

[0050] Dissolve 10.0 g of THP-protected dehydroepiandrosterone in 50 ml of THF after anhydrous ...

Example Embodiment

[0061] Example 2 Synthesis of Abiraterone Acetate

[0062] (1) Protection of hydroxyl

[0063] Dissolve 10.0 g of dehydroepiandrosterone in 80 ml of THF, add 4.5 g of trimethylchlorosilane (TMSCl) under stirring at room temperature, and add 7.5 ml of triethylamine as an acid binding agent, and stir the reaction solution at room temperature for 10-12 hours.

[0064] The reaction solution was desolventized under reduced pressure, the residue was dissolved in 100ml water and 100ml ethyl acetate, and the layers were separated. The aqueous phase was extracted twice with 50ml of ethyl acetate each time. The ethyl acetate phases were combined and washed once with 150ml of water. Washed with 150ml of saturated brine once, dried with anhydrous sodium sulfate and desolventized to obtain 12.1g of product (yield 97%), without purification, it can be used directly in the next reaction.

[0065] (2) Aldol reaction

[0066] Dissolve 10.0 g of THP-protected dehydroepiandrosterone in 50 ml of THF after...

Example Embodiment

[0077] Example 3 Synthesis of Abiraterone Acetate

[0078] (1) Protection of hydroxyl

[0079] Dissolve 10.0 g of dehydroepiandrosterone in 80 ml of DMF, add 6.3 g of trimethylchlorosilane (TBSCl) under stirring at room temperature, and add 3.3 g of imidazole as an acid binding agent, and stir the reaction solution for 10-12 hours at room temperature.

[0080] The reaction solution was poured into 100ml water, the phase was extracted three times with 50ml of ethyl acetate each time, the ethyl acetate phases were combined, washed once with 150ml of water, washed once with 150ml of saturated brine, dried with anhydrous sodium sulfate and desolventized to obtain 13.5g of crude product, quickly purified using thin-layer silica gel cake to obtain 12.8g (92% yield), which can be used in the next reaction.

[0081] (2) Aldol reaction

[0082] Dissolve 12.0 g of THP-protected dehydroepiandrosterone in 50 ml of THF after anhydrous treatment, and pre-cool for use.

[0083] Dissolve 5.2 g of 3-bro...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a novel method for preparing abiraterone acetate. The method comprises the following steps of: hydroxyl protection, Aldol reaction, dehydration reaction, deprotection and acetylation. According to the method, the heavy-metal reagent, the strict anhydrous and anaerobic equipment and the expensive alkyl boron reagent are not used, thus the cost is reduced greatly. The method is suitable for mass industrial production.

Description

technical field [0001] The invention relates to a preparation method of chemicals, in particular to a preparation method of abiraterone acetate. Background technique [0002] Abiraterone acetate, the chemical name is 17-(3-pyridyl)androst-5,16-diene-3beta-ethanol ester, the molecular structure is shown in the following formula: [0003] [0004] Abiraterone acetate is converted into abiraterone in the body. Abiraterone is an androgen synthesis inhibitor that can inhibit 17α-hydroxylase / C17,20-lyase (CYP17), which is expressed in testis, adrenal gland and prostate tumor tissue It is expressed in and is necessary for the biosynthesis of androgens. [0005] The growth of prostate cancer cells requires the supply of male hormones, and patients can be removed by surgery or radiotherapy. The goal of treatment is to prevent the testicles from making testosterone and other male hormones, and one option is surgical removal of the testicles. Another treatment option is to use dr...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07J43/00
CPCY02P20/55
Inventor 刘珂牟英波郎跃武
Owner SUZHOU LEINA PHARMA RES DEV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products